Ehlerding EB - Search Results

1

Site-Specific Immuno-PET Tracer to Image PD-L1.

Wissler HL, Ehlerding EB, Lyu Z, Zhao Y, Zhang S, Eshraghi A, Buuh ZY, McGuth JC, Guan Y, Engle JW, Bartlett SJ, Voelz VA, Cai W, Wang RE. Wissler HL, et al. Among authors: ehlerding eb. Mol Pharm. 2019 May 6;16(5):2028-2036. doi: 10.1021/acs.molpharmaceut.9b00010. Epub 2019 Mar 25. Mol Pharm. 2019. PMID: 30875232 Free PMC article.

2

ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.

England CG, Jiang D, Hernandez R, Sun H, Valdovinos HF, Ehlerding EB, Engle JW, Yang Y, Huang P, Cai W. England CG, et al. Among authors: ehlerding eb. Mol Pharm. 2017 Oct 2;14(10):3239-3247. doi: 10.1021/acs.molpharmaceut.7b00216. Epub 2017 Sep 6. Mol Pharm. 2017. PMID: 28825843 Free PMC article.

3

Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models.

Kang L, Jiang D, Ehlerding EB, Barnhart TE, Ni D, Engle JW, Wang R, Huang P, Xu X, Cai W. Kang L, et al. Among authors: ehlerding eb. Mol Pharm. 2018 Apr 2;15(4):1627-1634. doi: 10.1021/acs.molpharmaceut.7b01168. Epub 2018 Mar 20. Mol Pharm. 2018. PMID: 29537283 Free PMC article.

4

^86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model.

Ehlerding EB, Ferreira CA, Aluicio-Sarduy E, Jiang D, Lee HJ, Theuer CP, Engle JW, Cai W. Ehlerding EB, et al. Mol Pharm. 2018 Jul 2;15(7):2606-2613. doi: 10.1021/acs.molpharmaceut.8b00133. Epub 2018 May 30. Mol Pharm. 2018. PMID: 29787283 Free PMC article.

5

Noninvasive Imaging and Quantification of Radiotherapy-Induced PD-L1 Upregulation with ⁸⁹Zr-Df-Atezolizumab.

Ehlerding EB, Lee HJ, Barnhart TE, Jiang D, Kang L, McNeel DG, Engle JW, Cai W. Ehlerding EB, et al. Bioconjug Chem. 2019 May 15;30(5):1434-1441. doi: 10.1021/acs.bioconjchem.9b00178. Epub 2019 Apr 19. Bioconjug Chem. 2019. PMID: 30973703 Free PMC article.

6

^86/90Y-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics.

Ferreira CA, Ehlerding EB, Rosenkrans ZT, Jiang D, Sun T, Aluicio-Sarduy E, Engle JW, Ni D, Cai W. Ferreira CA, et al. Among authors: ehlerding eb. Mol Pharm. 2020 May 4;17(5):1697-1705. doi: 10.1021/acs.molpharmaceut.0c00127. Epub 2020 Mar 31. Mol Pharm. 2020. PMID: 32202792 Free PMC article.

7

ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.

Ehlerding EB, England CG, Majewski RL, Valdovinos HF, Jiang D, Liu G, McNeel DG, Nickles RJ, Cai W. Ehlerding EB, et al. Mol Pharm. 2017 May 1;14(5):1782-1789. doi: 10.1021/acs.molpharmaceut.7b00056. Epub 2017 Apr 12. Mol Pharm. 2017. PMID: 28388076 Free PMC article.

8

CD38 as a PET Imaging Target in Lung Cancer.

Ehlerding EB, England CG, Jiang D, Graves SA, Kang L, Lacognata S, Barnhart TE, Cai W. Ehlerding EB, et al. Mol Pharm. 2017 Jul 3;14(7):2400-2406. doi: 10.1021/acs.molpharmaceut.7b00298. Epub 2017 Jun 8. Mol Pharm. 2017. PMID: 28573863 Free PMC article.

9

Noninvasive PET Imaging of T cells.

Wei W, Jiang D, Ehlerding EB, Luo Q, Cai W. Wei W, et al. Among authors: ehlerding eb. Trends Cancer. 2018 May;4(5):359-373. doi: 10.1016/j.trecan.2018.03.009. Epub 2018 Apr 17. Trends Cancer. 2018. PMID: 29709260 Free PMC article. Review.

10

Multimodality Imaging Agents with PET as the Fundamental Pillar.

Ni D, Ehlerding EB, Cai W. Ni D, et al. Among authors: ehlerding eb. Angew Chem Int Ed Engl. 2019 Feb 25;58(9):2570-2579. doi: 10.1002/anie.201806853. Epub 2018 Dec 11. Angew Chem Int Ed Engl. 2019. PMID: 29968300 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page